This study examines the relationship between cellular sphingomyelin content and the distribution of unesterified cholesterol between the plasma-membrane pool and the putative intracellular regulatory pool. The sphingomyelin content of cultured human skin fibroblasts was reduced by treatment of intact cells with extracellularly added neutral sphingomyelinase, and subsequent changes in the activities of cholesterolmetabolizing enzymes were determined. Exposure of fibroblasts to 0.1 unit of sphingomyelinase/ml for 60 min led to the depletion of more than 90 % of the cellular sphingomyelin, as determined from total lipid extracts. In a time-course study, it was found that within 10 min of the addition of sphingomyelinase to cells, a dramatic increase in acyl-CoA cholesterol acyltransferase activity could be observed, whether measured from the appearance of plasma membrane-derived [3H] 
INTRODUCTION
Unesterified cholesterol is an essential structural component of membranes in living cells. Its distribution among different membrane structures is, however, not uniform. Cholesterol is relatively abundant in plasma membranes, whereas the concentration is lower in endoplasmic reticulum and lower still in mitochondrial membranes (Ashworth & Green, 1970; Keenan & Moore, 1970; Jain, 1975; Schroeder et al., 1976) . It is generally believed that the phospholipid composition of a membrane structure is a major determinant of the association of cholesterol with that particular compartment. The partitioning and exchange of cholesterol between membrane structures (both biological and artificial), or among isolated cell organelles, is greatly affected by the polar-head-group composition of the membrane phospholipids (Wattenberg & Silbert, 1983; Clejan & Bittman, 1984a , 1984b and by the phospholipid acyl chain length and saturation (Demel et al., 1972; Bloj & Zilversmith, 1977; Fugler et al., 1985; Child et al., 1985) . Interestingly, membranes with a high content of sphingomyelin and/or saturated phospholipid acyl chains (e.g. plasma membranes) also contain a relatively high concentration of cholesterol (Colbeau et al., 1971; Comte et al., 1976; Schroeder et al., 1976) . On the other hand, membranes high in polyunsaturated phospholipids and low in sphingomyelin (e.g. mitochondria), contain very low concentrations of cholesterol. Hence, sphingomyelin as well as saturated phosphatidylcholines are believed to have higher affinities for cholesterol than unsaturated phosphatidylcholines (Demel et al., 1977; Wattenberg & Silbert, 1983; van Blitterswijk et al., 1987) .
Previous studies from this laboratory have shown that incorporation of exogenous sphingomyelin into cultured fibroblasts results in a marked redistribution of cholesterol within the cells, as indicated by the increased rate of cholesterol biosynthesis observed in such cells (Gatt & Bierman, 1980; Kudchodkar et al., 1983) . In this study the effects of sphingomyelin depletion on the redistribution of plasma membrane-derived cholesterol within intact cells were tested. Results 0.100 (v/v) ] for 1 h at 37 'C. With this treatment, the major part of the label is associated with the cell surface and the plasma membrane (Lange & Ramos, 1983; Slotte & Bierman, 1987 [''C] oleic acid complexed to albumin (Oram et al., 1980 . Free and esterified cholesterol were separated on silica-gel H t.l.c. plates (Analtech, Newark, DE 19711, U.S.A.) with hexane/diethyl ether/glacial acetic acid (135:30:1.5, by vol.) as solvent. The cellular mass of unesterified cholesterol and cholesteryl ester mass (after alkaline hydrolysis to unesterified cholesterol) was determined by a cholesterol oxidase method (Heider & Boyett, 1978 For extraction of cellular total lipids, cells were detached from the dishes by gentle scraping (teflon scraper). The cells were then pelleted by slow-speed centrifugation and the lipids were extracted by the Folch (1957) procedure. The extracted phospholipids were separated on silica-gel H plates developed in chloroform/ methanol/glacial acetic acid/water (75:45:12:6, by vol.) (Skipski et al., 1964) . The individual phospholipid classes were quantified by the method of Bartlett (1959) .
Cell proteins remaining on dishes after hexane/ isopropanol extraction were digested into 1.0 ml of 0.1 MNaOH (1 h at room temperature). A portion was taken for protein determination by the method of Lowry et al. (1951) with bovine albumin as standard.
RESULTS
Effects of sphingomyelinase treatment on cellular lipid composition Confluent human skin fibroblasts, pre-incubated in serum-free DMEM for 24 h, were exposed to 0.1 unit of sphingomyelinase for 1 h at 37 'C. This treatment dramatically and specifically decreased the mass of sphingomyelin in the cell total-lipid extract (Table 1) . The amounts of phosphatidylcholine, phosphatidylinositol, or phosphatidylethanolamine were not altered by the sphingomyelinase treatment, as compared with untreated cells. We assume that most of the sphingomyelin that was degraded by sphingomyelinase was localized in the plasma membrane, since plasma membranes normally contain most of the cell sphingomyelin (Colbeau et al., 1971 ; Comte et al., 1976; Schroeder et al., 1976) . The batch of enzyme used was not contaminated by proteases, since the total amount of protein per dish was similar in treated and untreated cells. Also, the total mass of cholesterol (sum of free and esterified cholesterol) in cells was unaffected by the 1 h exposure to 0.1 unit of sphingomyelinase/ml ( (Slotte, 1987) , an enzyme localized in the RNA-rich endoplasmic reticulum (Balasubramaniam et al., 1978; Hashimoto & Fogelman, 1980 was very limited (Fig. 1) . This is consistent with previously reported observations under comparable incubation conditions (Lange & Matthies, 1984; Slotte & Bierman, 1987) . However, when the cellular content of sphingomyelin was depleted, a dramatic increase in the esterification of plasma membrane-derived [3H]-cholesterol was observed (Fig. 1) (Fig. 2) . Since the depletion of sphingomyelin resulted in increased esterification of both plasma membrane-derived [3H]cholesterol and exogenously added ["4C]oleic acid, we think this implies that sphingomyelin depletion resulted in a redistribution ofcholesterol mass within the cell, leading to a net flow of cholesterol into the endoplasmic reticulum which secondarily (and rapidly) activated ACAT. Consistent with this interpretation was the observation that the sphingomyelinase treatment, in addition to increasing the esterification of the radioactive tracers used, also led to an increase in cell cholesteryl ester mass. In cells exposed to sphingomyelinase for 3 h in the absence of an exogenous source of cholesterol, the cholesteryl ester content was about 7000 higher compared to untreated cells (7.1 + 0.4 versus 4.2 + 0.1 nmol of sterol equivalents/mg of cell protein for sphingomyelindepleted and control cells respectively; Table 2 ). Effects of sphingomyelinase treatment on the rate of synthesis de novo of I'4Cicholesterol from sodium
I14Clacetate
We hypothesized that if the sphingomyelinase treatment increased the activity of ACAT by effecting a net flow of sterol mass into the endoplasmic reticulum, we should also be able to see a down-regulation of the endogenous synthesis of cholesterol after sphingomyelin depletion . To test this hypothesis, we measured the effect of sphingomyelinase To test the hypothesis that sphingomyelin depletion reduced the capacity of the plasma membranes to solubilize and hence also to incorporate cholesterol, we measured how the sphingomyelinase treatment affected the ability of plasma membranes to incorporate exogenously added [3H]cholesterol. Two different labelling protocols were used. First, fibroblasts were pulsed for 1 h at 37°C with 0.5 ,uCi of [3H]cholesterol/ml (15 nM). Then, after appropriate rinsing of cells with phosphatebuffered saline, the cells were exposed to 0.1 unit of sphingomyelinase/ml in serum-free DMEM for an additional 60 min. With this protocol the cellular incorporation of [3H]cholesterol was similar in control and sphingomyelinase-treated cells (Table 4) , since the uptake was completed before the plasma-membrane sphingomyelin was depleted and no loss ofcell-associated
[3H]cholesterol occurred during the enzyme treatment.
With the other labelling procedure, cells were simultaneously exposed to 0.5 ,uCi of [3H]cholesterol/ml and 0.1 unit of sphingomyelinase/ml. With this second procedure it was evident that cells exposed to sphingomyelinase incorporated 25 % less [3H]cholesterol compared with cells not exposed to sphingomyelinase (Table 4) . Hence it appears that plasma membranes depleted of sphingomyelin were able to incorporate less [3H]cholesterol than native sphingomyelin-containing membranes.
DISCUSSION
Results in this study have demonstrated that a minor alteration in the phospholipid composition of the cellular plasma membranes markedly affects the capacity of the membrane bilayer to solubilize cholesterol, and hence affects the steady-state distribution ofcholesterol between plasma membranes and other cellular organelles. Depletion of sphingomyelin from cells with neutral sphingomyelinase resulted in a rapid flow of cholesterol from the cell surface to intracellular cholesterol pools. This conclusion is supported by: (i) the increased esterification of plasma membrane-derived free [3Hlcholesterol; (ii) (Wattenberg & Silbert, 1983; van Blitterswijk et al., 1987) . It is also apparent that the plasma membranes of fibroblasts are saturated with respect to their capacity to solubilize cholesterol, since a relatively small reduction in the plasma-membrane phospholipid composition (a reduction of about 5 mol % in the total cell phospholipids) led to such a rapid mass movement of cholesterol away from the cell surface to The movement of plasma membrane-derived cholesterol to the substrate pool of ACAT was very rapid. It is plausible that the rapid increase in the cellular esterification activity was at least in part a result of more cholesterol appearing in the substrate pool of ACAT. Previous studies have suggested that ACAT, in cholesterol-depleted cells, may operate below optimal substrate saturation (Nilsson, 1975; Mathur et al., 1981; Mitropoulos et al., 1984) . If that were the case in these cells, then one would expect to see a rapid increase in the activity of the ACAT reaction if there was a net flow of cholesterol mass into the substrate pool of this enzyme. However, other more complicated regulatory mechanisms could be involved in the observed up-regulation of ACAT (Hashimoto et al., 1983; Chang et al., 1986) .
Both the up-regulation of ACAT activity and the down-regulation of the cholesterol biosynthetic pathway clearly suggest that the depletion of cell surface sphingomyelin led to a redistribution of cholesterol mass from
Vol. 250 the cell surface into the intracellular putative regulatory pool of free cholesterol. The metabolic responses to the degradation of cell sphingomyelin in this study were exactly opposite to the corresponding responses observed in fibroblasts enriched with sphingomyelin (Gatt & Bierman, 1980; Kudchodkar et al., 1983) . In those studies accumulation of sphingomyelin in cultured fibroblasts led to increased synthesis of cholesterol de novo and to a decreased mass of cellular cholesteryl esters. Hence it appears that sphingomyelin, by its ability to attract cholesterol to itself or to the microenvironment where it resides, can influence the steady-state distribution of cholesterol mass between the sphingomyelin-rich environment and other cellular environments.
Two basic conclusions can be drawn from this study. First, these results confirm previous results from other studies that sphingomyelin is an important determinant of the distribution of cholesterol within intact cells. Secondly, it is obvious that plasma-membrane cholesterol has the potential to be rapidly transported from the cell surface to intracellular cholesterol pools, whenever the cholesterol-solubilizing capacity of the plasma membranes is reduced. This is an important finding, since it shows that plasma-membrane cholesterol is not metabolically isolated from the putative intracellular regulatory pool of cholesterol.
